Evan Melrose

Active Investor

CEO at Elevage Medical Technologies

Austin, Texas

Evan Melrose, CEO at Elevage Medical Technologies is an active investor based in Austin, Texas. This profile covers what Evan Melrose backs, at which stage, and how founders can reach out in 2026.

Investor type: VCPE
Stages: SeedSeries ASeries BLate Stage Venture
Invests in: Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaMedTech & Medical DevicesSaaS & Enterprise
Location: Austin, Texas
Typical check: $2M
Past investments: 19

Notable investments

BioSET (acquired by Ferring Pharmaceuticals)HNI HealthcareZiopharm Oncology (Nasdaq: ZIOP)Burrill & CompanyEdgemont Pharmaceuticals acquired by Alvogen (CVC Capital)Qspex TechnologiesBioventus (Nasdaq: BVS)Alexza Pharmaceuticals (Nasdaq: ALXA acquired by Ferrer)IDEV Technologies (acquired by Abbott NYSE: ABT)AMERICAN ACADEMY OF FAMILY PHYSICIANS-VIRGINIA ACADEMYBiomimetic Therapeutics (Nasdaq: BMTI)Accumetrics acquired by Accriva Diagnostics (Warburg Pincus)

How to reach Evan Melrose

Angels and operators like Evan Melrose reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Evan Melrose invest in?

Evan Melrose invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and MedTech & Medical Devices, typically at Seed, Series A, Series B and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.